Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 500 of 715 entries
View as:

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT00925730 Org: User:
Start: 03/31/04 End: - Due: -

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00232011 Org: User:
Start: 05/31/04 End: 05/31/05 Due: 05/31/06

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT01068600 Org: User:
Start: 01/31/10 End: - Due: -

A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00817635 Org: User:
Start: 12/22/08 End: 10/13/09 Due: 10/13/10

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00138606 Org: User:
Start: 01/31/05 End: 01/31/06 Due: 01/31/07

Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00746330 Org: User:
Start: 08/31/08 End: 04/30/09 Due: 04/30/10

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT00464672 Org: User:
Start: 04/30/07 End: 12/31/07 Due: 12/31/08

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Phase: N/A Priority: Normal
NCT ID: NCT00250562 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib

Phase: N/A Priority: Normal
NCT ID: NCT06516029 Org: User:
Start: 04/21/23 End: 10/02/23 Due: 10/02/24

A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)

Phase: N/A Priority: Normal
NCT ID: NCT02235740 Org: User:
Start: 11/30/14 End: 10/31/15 Due: 10/31/16

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00624702 Org: User:
Start: 02/29/08 End: 09/30/08 Due: 09/30/09

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00529451 Org: User:
Start: 09/30/07 End: 07/31/08 Due: 07/31/09

A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00785083 Org: User:
Start: 09/30/08 End: - Due: -

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Phase: N/A Priority: Normal
NCT ID: NCT01023815 Org: User:
Start: 04/30/09 End: 07/31/12 Due: 07/31/13

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00098150 Org: User:
Start: 07/31/04 End: - Due: -

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00651105 Org: User:
Start: 02/29/08 End: - Due: -

Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough

Phase: N/A Priority: Normal
NCT ID: NCT02379637 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00241007 Org: User:
Start: 12/31/03 End: 03/31/05 Due: 03/31/06

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00463801 Org: User:
Start: 01/31/07 End: - Due: -

Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00416845 Org: User:
Start: 10/31/06 End: - Due: -

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00171665 Org: User:
Start: 05/31/05 End: 12/31/05 Due: 12/31/06

Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT00481676 Org: User:
Start: 05/31/07 End: 04/30/09 Due: 04/30/10

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00418002 Org: User:
Start: 05/31/06 End: - Due: -

Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT00275821 Org: User:
Start: 12/31/05 End: 01/31/08 Due: 01/31/09

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00482508 Org: User:
Start: 05/31/03 End: 10/31/05 Due: 10/31/06